{
  "ptid_time": "041_S_4143_2017-07-27",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4143/2017-07-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 67,593 mm³, 202.6% above the reference mean. With a Z-score of 5.07 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 4,387 mm³, 42.9% below the reference mean. With a Z-score of -4.82 (0.0th percentile), this represents profound atrophy; whole brain volume measures 862,657 mm³, 16.2% below the reference mean. With a Z-score of -2.01 (2.2th percentile), this represents significant atrophy; entorhinal cortex volume measures 1,403 mm³, 64.0% below the reference mean. With a Z-score of -4.96 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 13,101 mm³, 28.1% below the reference mean. With a Z-score of -3.16 (0.1th percentile), this represents profound atrophy; middle temporal gyrus volume measures 13,937 mm³, 32.1% below the reference mean. With a Z-score of -2.85 (0.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 69.6 years. Gender is Female. Education: 19 years. MMSE: 23.0. MoCA: 21.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.01 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus, middle temporal gyrus) alongside significant whole-brain atrophy and ventricular enlargement. The cognitive scores (MMSE 23, MoCA 21) are below normal for age, suggesting cognitive impairment, but not severe enough for dementia. The absence of APOE4 and normal AV45 (amyloid PET) makes typical Alzheimer's less likely, but the structural changes strongly suggest neurodegeneration.  \n\n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (Cognitive scores align with MCI, but the severity of atrophy is more typical of dementia; however, the absence of amyloid pathology lowers confidence in an Alzheimer's-specific diagnosis.)",
  "timestamp": "2025-07-26T07:14:14.181174"
}